Skip to content
Home/Companies/Pharma/DOC Generici

DOC Generici

Pharma·France·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns DOC Generici?

DOC Generici is a French Pharma company, now owned by TPG Capital, which acquired it in 2022 from Merieux Equity Partners.

ICG is still listed as an investor in DOC Generici, status not confirmed after the 2022 sale.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
ICG
Most recent investor
ICG
ICG Europe Mid-Market Fund I · 2019 · Buyout
4 ownership periods · full history below

Key facts

HQFrance
SectorPharma
Key takeaways
  • ·Held by ICG since 2019 (7Y hold).
  • ·Average hold across 3 realized cycles: 3 years.
  • ·4 distinct PE sponsors across ownership cycles.

Ownership history

4 ownership periods · co-invest detected

Active
Currently held by ICG since 2019.
Charterhouse Capital Partners
Charterhouse Capital PartnersExited 2016
2013 · 2016(3yr) · Charterhouse Capital Partners IX · 2009 · Buyout
Secondary · to CVC Capital Partners

Charterhouse Capital Partners sold DOC Generici to CVC Capital Partners in 2016 after 3 years.

CVC Capital Partners
CVC Capital PartnersExited 2019
2016 · 2019(3yr) · CVC Capital Partners Fund VI · 2013 · Buyout
Secondary · to ICG

CVC Capital Partners sold DOC Generici to ICG in 2019 after 3 years.

Co-invest · 2 holders · 2019 · present
Merieux Equity Partners
Merieux Equity PartnersExited 2022
2019 · 2022(3yr) · Mérieux Participations 3 · 2019 · Buyout
Trade Sale · to TPG Capital

Merieux Equity Partners sold DOC Generici to TPG Capital in 2022 after 3 years.

ICG
ICGActive
2019 · present(7yr) · ICG Europe Mid-Market Fund I · 2019 · Buyout

More from ICG Europe Mid-Market Fund I

Other portfolio companies in the same fund.

Staysure Group
Staysure Group
Active
InsurTechUK· 2024
Alvinesa
Active
IndustrialsSpain· 2021
Atos (clinics)
Active
HealthcareGermany· 2021
Formue
Formue
Active
FinancialsNorway· 2021
Godt Smil
Godt Smil
Active
HealthcareDenmark· 2021
Iver
Active
IT ServicesSweden· 2021

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns DOC Generici?

DOC Generici is now owned by TPG Capital, which acquired it in 2022 from Merieux Equity Partners. ICG is still listed as an investor in DOC Generici, status not confirmed after the 2022 sale.

When did TPG Capital acquire DOC Generici?

TPG Capital acquired DOC Generici in 2022, buying from Merieux Equity Partners.

Who did DOC Generici sell to?

Merieux Equity Partners sold DOC Generici to TPG Capital in 2022 (Trade Sale). CVC Capital Partners sold DOC Generici to ICG in 2019 (Secondary). Charterhouse Capital Partners sold DOC Generici to CVC Capital Partners in 2016 (Secondary).

Who has owned DOC Generici over time?

DOC Generici has been through 4 private-equity ownership periods: Charterhouse Capital Partners · via Charterhouse Capital Partners IX · 2013–2016 · sold to CVC Capital Partners · (Secondary); CVC Capital Partners · via CVC Capital Partners Fund VI · 2016–2019 · sold to ICG · (Secondary); Merieux Equity Partners · via Mérieux Participations 3 · 2019–2022 · sold to TPG Capital · (Trade Sale); ICG · via ICG Europe Mid-Market Fund I · since 2019.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue